Loading…
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma
Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genomewide association study in the No...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells.
While first-degree relatives of patients with MM show an increased risk of MM, the genetic
basis of inherited MM susceptibility is incompletely understood. Here we report a genomewide
association study in the Nordic region identifying a novel MM risk locus at ELL2
(rs56219066T; odds ratio (OR)=1.25; P=9.6 x10 -10). This gene encodes a stoichiometrically
limiting component of the super-elongation complex that drives secretory-specific
immunoglobulin mRNA production and transcriptional regulation in plasma cells.We find that
the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for
transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk
allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy
subjects (P=8.6x 10- 9 and P=6.4x 10- 3, respectively) and, potentially, with an
increased risk of bacterial meningitis (OR=1.30; P=0.0024). |
---|